Crabel Capital Management, LLC / TREUR
Crabel Capital Management, LLC’s Trillium Therapeutics Inc Position
Does Crabel Capital Management, LLC own Trillium Therapeutics Inc (TREUR)? Not currently — the last reported position was 423.5K shares worth $7M in Q3 2021; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$7M
Q3 2021
Shares
423.5K
% of Portfolio
+2.29%
Quarters Held
1
position exited
Position History TREUR
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2021 | 423.5K | $7M | +2.29% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Crabel Capital Management, LLC’s full portfolio or all institutional holders of TREUR.